Search Results 881-890 of 13633 for Assay

  1. A Study to Evaluate INO-3107 with Electroporation (EP) in Participants with HPV-6- and/or HPV-11-Associated Recurrent Respiratory Papillomatosis (RRP) - Mayo Clinic

    ... assay. Have a requirement for frequent RRP intervention in order to remove or resect respiratory papilloma, as defined as at least two RRP surgical ...

  2. S1602: Different Strains of BCG With or Without Vaccine in High Grade Non- Muscle Invasive Bladder Cancer - Mayo Clinic

    If PPD is not available, then a negative Interferon Gamma Release Assay (IGRA) may be used. The PPD or IGRA test results must be obtained within 90 days ...

  3. Study of the Safety and Efficacy of STI-6129 in Patients With Relapsed or Refractory Systemic AL Amyloidosis - Mayo Clinic

    Measurable disease defined as the finding by serum-free light chain (FLC) assay that the difference between the involved and uninvolved FLC (dFLC) is ≥ 50 mg/L ...

  4. Dose-Escalation Study of cevostamab (BFCR4350A) in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM) - Mayo Clinic

    Serum free light chain (SFLC) assay. Laboratory values as follows: Hepatic function. AST and ALT ≤ 3 ≤ ULN; Total bilirubin ≤ 1.5 x ULN; patients with a ...

  5. A Study to Evaluate the Effectiveness of Spesolimab to Treat Hidradenitis Suppurativa - Mayo Clinic

    Participation eligibility · Patients with active tuberculosis should be excluded; · Patients will be screened with Interferon Gamma Release Assay (IGRA) such as ...

  6. Phase II Single-arm Study of Tepotinib Combined with Cetuximab - Mayo Clinic

    ... assay; AND a barrier method,; During the intervention period;; After the study intervention period (i.e., after the last dose of study intervention is ...

  7. Discovery Science - 2019 Archives

    In his recent book, The Body, Bill Bryson reports that according to the Royal Society of Chemistry, the materials needed to build a human would[...].

  8. Evaluation of Laboratory Methods for Detecting Auto Antibodies to Complement Proteins - Mayo Clinic

    The goal of this study is to validate testing to be performed in the clinical immunology lab and have a source of positive patient sera. These tests include:.

  9. A Study to Evaluate the Disease Development and Impact of Intravascular Volume Expansion Profiles in Relation to Neuroendocrine and Renal Function in Post-Acute Heart Failure - Mayo Clinic

    ... assay to the laboratory that developed the equation. The 4-variable equation from the Modification of Diet in Renal Disease (MDRD) Study has been ...

  10. Study of bb21217 in Multiple Myeloma - Clinical Trials

    Serum free light chain (FLC) assay: involved FLC level greater or equal to 10 mg/dL (100 mg/L) provided serum FLC ratio is abnormal. For Part A (Dose ...